Trastuzumab emtansine versus treatment of physician's choice for pretreated HER2-positive advanced breast cancer (TH3RESA): a randomised, open-label, phase 3 trial
2014 ◽
Vol 15
(7)
◽
pp. 689-699
◽
Keyword(s):
Phase 3
◽
2020 ◽
Keyword(s):